BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

747 related articles for article (PubMed ID: 25058643)

  • 1. Generating genetically modified mice using CRISPR/Cas-mediated genome engineering.
    Yang H; Wang H; Jaenisch R
    Nat Protoc; 2014 Aug; 9(8):1956-68. PubMed ID: 25058643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The new CRISPR-Cas system: RNA-guided genome engineering to efficiently produce any desired genetic alteration in animals.
    Seruggia D; Montoliu L
    Transgenic Res; 2014 Oct; 23(5):707-16. PubMed ID: 25092533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene targeting technologies in rats: zinc finger nucleases, transcription activator-like effector nucleases, and clustered regularly interspaced short palindromic repeats.
    Mashimo T
    Dev Growth Differ; 2014 Jan; 56(1):46-52. PubMed ID: 24372523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of Genetically Modified Mice Using the CRISPR-Cas9 Genome-Editing System.
    Henao-Mejia J; Williams A; Rongvaux A; Stein J; Hughes C; Flavell RA
    Cold Spring Harb Protoc; 2016 Feb; 2016(2):pdb.prot090704. PubMed ID: 26832688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Making the cut.
    Travis J
    Science; 2015 Dec; 350(6267):1456-7. PubMed ID: 26680172
    [No Abstract]   [Full Text] [Related]  

  • 6. GONAD: Genome-editing via Oviductal Nucleic Acids Delivery system: a novel microinjection independent genome engineering method in mice.
    Takahashi G; Gurumurthy CB; Wada K; Miura H; Sato M; Ohtsuka M
    Sci Rep; 2015 Jun; 5():11406. PubMed ID: 26096991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Principles of Genetic Engineering.
    Lanigan TM; Kopera HC; Saunders TL
    Genes (Basel); 2020 Mar; 11(3):. PubMed ID: 32164255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR/Cas-mediated genome editing in the rat via direct injection of one-cell embryos.
    Shao Y; Guan Y; Wang L; Qiu Z; Liu M; Chen Y; Wu L; Li Y; Ma X; Liu M; Li D
    Nat Protoc; 2014 Oct; 9(10):2493-512. PubMed ID: 25255092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AAV-Mediated CRISPR/Cas Gene Editing of Retinal Cells In Vivo.
    Hung SS; Chrysostomou V; Li F; Lim JK; Wang JH; Powell JE; Tu L; Daniszewski M; Lo C; Wong RC; Crowston JG; Pébay A; King AE; Bui BV; Liu GS; Hewitt AW
    Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3470-6. PubMed ID: 27367513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome engineering using the CRISPR-Cas9 system.
    Ran FA; Hsu PD; Wright J; Agarwala V; Scott DA; Zhang F
    Nat Protoc; 2013 Nov; 8(11):2281-2308. PubMed ID: 24157548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From Gene Targeting to Genome Editing: Transgenic animals applications and beyond.
    Rocha-Martins M; Cavalheiro GR; Matos-Rodrigues GE; Martins RA
    An Acad Bras Cienc; 2015 Aug; 87(2 Suppl):1323-48. PubMed ID: 26397828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breakthrough to genome editing.
    McNutt M
    Science; 2015 Dec; 350(6267):1445. PubMed ID: 26680163
    [No Abstract]   [Full Text] [Related]  

  • 13. Plant genome engineering in full bloom.
    Lozano-Juste J; Cutler SR
    Trends Plant Sci; 2014 May; 19(5):284-7. PubMed ID: 24674878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering.
    Wang H; Yang H; Shivalila CS; Dawlaty MM; Cheng AW; Zhang F; Jaenisch R
    Cell; 2013 May; 153(4):910-8. PubMed ID: 23643243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of microinjection methods for generating knockout mice by CRISPR/Cas-mediated genome engineering.
    Horii T; Arai Y; Yamazaki M; Morita S; Kimura M; Itoh M; Abe Y; Hatada I
    Sci Rep; 2014 Mar; 4():4513. PubMed ID: 24675426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR-Cas systems for editing, regulating and targeting genomes.
    Sander JD; Joung JK
    Nat Biotechnol; 2014 Apr; 32(4):347-55. PubMed ID: 24584096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA-guided human genome engineering via Cas9.
    Mali P; Yang L; Esvelt KM; Aach J; Guell M; DiCarlo JE; Norville JE; Church GM
    Science; 2013 Feb; 339(6121):823-6. PubMed ID: 23287722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR-Cas9: A revolution in genome editing in rheumatic diseases.
    Duroux-Richard I; Giovannangeli C; Apparailly F
    Joint Bone Spine; 2017 Jan; 84(1):1-4. PubMed ID: 27825565
    [No Abstract]   [Full Text] [Related]  

  • 19. Crispr-mediated Gene Targeting of Human Induced Pluripotent Stem Cells.
    Byrne SM; Church GM
    Curr Protoc Stem Cell Biol; 2015; 35(Suppl 35):5A.8.1-5A.8.22. PubMed ID: 26949444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Harnessing CRISPR-Cas systems for bacterial genome editing.
    Selle K; Barrangou R
    Trends Microbiol; 2015 Apr; 23(4):225-32. PubMed ID: 25698413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.